lysyl-aspartyl-glutamyl-leucine has been researched along with Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Meijer, J; Roos, E; Sipos, B; Zeelenberg, IS | 1 |
1 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and Adenocarcinoma
Article | Year |
---|---|
The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Chemokine CXCL13; Chemokines, CXC; Colonic Neoplasms; Drug Delivery Systems; Humans; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Neoplasm Transplantation; Oligopeptides; Organ Specificity; Pancreatic Neoplasms; Protein Sorting Signals; Receptors, Chemokine; Receptors, CXCR5; Recombinant Fusion Proteins; Spleen; Splenic Neoplasms; Transfection | 2006 |